Scott Adams, known for creating the long-running workplace-themed comic strip Dilbert, has publicly revealed that he is facing an advanced and aggressive form of prostate cancer. The 66-year-old says the disease has spread to his bones, and medical professionals have informed him that he may not live beyond this summer.
Speaking during a livestream on the video platform Rumble, Adams disclosed that he had kept the diagnosis private until now. Though he did not specify when he was first diagnosed, he implied that his condition predates President Joe Biden’s recently announced cancer battle. “I’ve had it longer than he’s admitted to having it,” Adams said, referencing Biden.
The announcement comes shortly after President Biden, 82, confirmed he is undergoing treatment for stage 4 prostate cancer, which has also metastasized to his bones. The overlapping timing of their disclosures has sparked broader discussions about prostate cancer and the importance of early detection.
Medical experts have raised concerns over Biden’s diagnosis timeline. On MSNBC, oncologist Dr. Zeke Emanuel remarked that the cancer likely existed prior to Biden’s time in office, suggesting it may have been undetected for years.
Adams rose to fame in the early 1990s thanks to Dilbert, which satirized office culture and corporate life. The strip became a global phenomenon, appearing in thousands of newspapers and translated into multiple languages.
In addition to his work in comics, Adams pursued writing and business ventures. He authored several books on topics ranging from society to philosophy, and founded a vegetarian food company that marketed unconventional products like the “Dilberito.” However, his outspoken views, especially on political and cultural issues, have led to significant backlash in recent years. In 2023, a series of controversial comments prompted newspapers and his syndication partner to sever ties with him.
Now confronting a terminal illness, Adams’ announcement adds a deeply personal note to ongoing conversations about men’s health, late-stage cancer diagnoses, and the unpredictable nature of public figures facing private medical battles.
